Viswanathan Hema, Bharmal Murtuza, Thomas Joseph
Department of Pharmacy Practice, Purdue University, West Lafayette, Indiana 47907-2091, USA.
Clin Ther. 2005 Jan;27(1):88-99. doi: 10.1016/j.clinthera.2005.01.009.
The aims of this study were to determine the prevalence of prescribing potentially inappropriate medications (PIMs) based on the 2002 Beers criteria among ambulatory patients aged > or =65 years, to compare PIM prevalence rates based on the 1997 Beers criteria and Zhan criteria with the rate obtained using the 2002 Beers criteria, and to examine patient, provider, and visit characteristics associated with receiving a PIM.
Retrospective analysis was conducted of the year-2001 public-use data files of the National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey. The 2002 Beers criteria 1997 Beers criteria, and Zhan criteria were used to determine presence of PIMs. Multivariate logistic regression was performed to identify patient, visit, and provider characteristics associated with receiving a PIM.
A total of 7243 ambulatory visits by individuals aged > or =65 years with > or =1 prescription were projected to an estimated 157 million such ambulatory visits. An estimated 21 million visits (13.4%) involved PIMs based on the 2002 Beers criteria, compared with 13.9 million visits (8.8%) based on the 1997 Beers criteria and 6.6 million visits (4.2%) based on the Zhan criteria. An additional 7.2 million visits (4.6%) by eligible patients involved medications defined by the Zhan criteria as having some indications but often being misused. After adjusting for other factors, visits made in metropolitan areas (odds ratio [OR], 2.42 195% Cl, 1.14-5.12) or by referred patients (OR, 2.28 195% CI, 1.43-3.61) were more likely to involve a PIM. Compared with visits involving 1 medication, those involving 2 (OR, 2.39 [95% CI, 1.30-4.41]), 3 (OR, 7.01 [95% Cl, 3.42-14.35]), or > or =4 medications (OR, 7.35 [95% Cl, 4.44-12.17]) were more likely to be associated with a PIM.
Prevalence of PIMs among ambulatory patients aged > or =65 years is high. The most frequently prescribed PIMs and positive risk factors warrant greater attention from a policy perspective.
本研究旨在确定基于2002年《Beers标准》的潜在不适当用药(PIMs)在65岁及以上门诊患者中的流行情况,比较基于1997年《Beers标准》和《Zhan标准》的PIMs流行率与使用2002年《Beers标准》得出的流行率,并研究与接受PIM相关的患者、医疗服务提供者及就诊特征。
对2001年全国门诊医疗护理调查和全国医院门诊医疗护理调查的公共使用数据文件进行回顾性分析。使用2002年《Beers标准》、1997年《Beers标准》和《Zhan标准》来确定PIMs的存在情况。进行多变量逻辑回归以识别与接受PIM相关的患者、就诊和医疗服务提供者特征。
年龄在65岁及以上且有≥1张处方的患者共有7243次门诊就诊,预计此类门诊就诊总数达1.57亿次。基于2002年《Beers标准》,估计有2100万次就诊(13.4%)涉及PIMs,相比之下,基于1997年《Beers标准》的有1390万次就诊(8.8%),基于《Zhan标准》的有660万次就诊(4.2%)。符合条件的患者还有720万次就诊(4.6%)涉及《Zhan标准》定义为有一些适应证但常被滥用的药物。在调整其他因素后,在大都市地区进行的就诊(优势比[OR],2.42;95%可信区间[CI],1.14 - 5.12)或由转诊患者进行的就诊(OR,2.28;95%CI,1.43 - 3.61)更有可能涉及PIM。与涉及1种药物的就诊相比,涉及2种(OR,2.39[95%CI,1.30 - 4.41])、3种(OR,7.01[95%CI,3.42 - 14.35])或≥4种药物的就诊(OR,7.35[95%CI,4.44 - 12.17])更有可能与PIM相关。
65岁及以上门诊患者中PIMs的流行率很高。从政策角度来看,最常开具的PIMs和阳性风险因素值得更多关注。